» Articles » PMID: 30657642

Beyond HIV Prevention: Everyday Life Priorities and Demand for PrEP Among Ugandan HIV Serodiscordant Couples

Overview
Journal J Int AIDS Soc
Date 2019 Jan 19
PMID 30657642
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Pre-exposure prophylaxis (PrEP) to prevent HIV infection is being rolled out in Africa. The uptake of PrEP to date has varied across populations and locations. We seek to understand the drivers of demand for PrEP through analysis of qualitative data collected in conjunction with a PrEP demonstration project involving East African HIV serodiscordant couples. Our goal was to inform demand creation by understanding what PrEP means - beyond HIV prevention - for the lives of users.

Methods: The Partners Demonstration Project evaluated an integrated strategy of PrEP and antiretroviral therapy (ART) delivery in which time-limited PrEP served as a "bridge" to long-term ART. Uninfected partners in HIV serodiscordant couples were offered PrEP at baseline and encouraged to discontinue once infected partners had taken ART for six months. We conducted 274 open-ended interviews with 93 couples at two Ugandan research sites. Interviews took place one month after enrolment and at later points in the follow-up period. Topics included are as follows: (1) discovery of serodiscordance; (2) decisions to accept/decline PrEP and/or ART; (3) PrEP and ART initiation; (4) experiences of using PrEP and ART; (5) PrEP discontinuation; (6) impact of PrEP and ART on the partnered relationship. Interviews were audio-recorded and transcribed. We used an inductive, content analytic approach to characterize meanings of PrEP stemming from its effectiveness for HIV prevention. Relevant content was represented as descriptive categories.

Results: Discovery of HIV serodiscordance resulted in fear of HIV transmission for couples, which led to loss of sexual intimacy in committed relationships, and to abandonment of plans for children. As a result, partners became alienated from each other. PrEP countered the threat to the relationship by reducing fear and reinstating hopes of having children together. Condom use worked against the re-establishment of intimacy and closeness. By increasing couples' sense of protection against HIV infection and raising the prospect of a return to "live sex" (sex without condoms), PrEP was perceived by couples as solving the problem of serodiscordance and preserving committed relationships.

Conclusions: The most effective demand creation strategies for PrEP may be those that address the everyday life priorities of potential users in addition to HIV prevention.

Clinical Trial Number: NCT02775929.

Citing Articles

Couple-centered HIV prevention and care: Endorsement, practice and uncertainty among us healthcare providers in western-central upstate New York.

LeBlanc N, Muheriwa-Matemba S, St Vil N, Alcena-Stiner D, Bond K, Glazier A PLoS One. 2025; 20(2):e0299185.

PMID: 39999108 PMC: 11856527. DOI: 10.1371/journal.pone.0299185.


A scoping review of qualitative studies on sexual and reproductive health and rights in Uganda: Exploring factors at multiple levels.

Buser J, Kumakech E, August E, Rana G, Gray R, Auma A Womens Health (Lond). 2024; 20:17455057241285193.

PMID: 39345026 PMC: 11452882. DOI: 10.1177/17455057241285193.


Barriers and facilitators to uptake and persistence on prep among key populations in Southern Province, Zambia: a thematic analysis.

Stoebenau K, Muchanga G, Ahmad S, Bwalya C, Mwale M, Toussaint S BMC Public Health. 2024; 24(1):1617.

PMID: 38886691 PMC: 11184712. DOI: 10.1186/s12889-024-19152-y.


Mobile Phone Technology for Preventing HIV and Related Youth Health Problems, Sexual Health, Mental Health, and Substance Use Problems in Southwest Uganda (Youth Health SMS): Protocol for a Pilot Randomized Controlled Trial.

Kreniske P, Namuyaba O, Kasumba R, Namatovu P, Ssewamala F, Wingood G JMIR Res Protoc. 2023; 12:e49352.

PMID: 38113102 PMC: 10762611. DOI: 10.2196/49352.


Clinical trial simulation to evaluate tenofovir disoproxil fumarate/emtricitabine HIV pre-exposure prophylaxis dosing during pregnancy.

Scott R, Yu Y, Marzinke M, Coleman J, Hendrix C, Bies R Front Reprod Health. 2023; 5:1224580.

PMID: 37830105 PMC: 10565828. DOI: 10.3389/frph.2023.1224580.


References
1.
Heffron R, Ngure K, Odoyo J, Bulya N, Tindimwebwa E, Hong T . Pre-exposure prophylaxis for HIV-negative persons with partners living with HIV: uptake, use, and effectiveness in an open-label demonstration project in East Africa. Gates Open Res. 2019; 1:3. PMC: 5757790. DOI: 10.12688/gatesopenres.12752.2. View

2.
Grant R, Lama J, Anderson P, McMahan V, Liu A, Vargas L . Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010; 363(27):2587-99. PMC: 3079639. DOI: 10.1056/NEJMoa1011205. View

3.
Blumenthal J, Haubrich R . Will risk compensation accompany pre-exposure prophylaxis for HIV?. Virtual Mentor. 2014; 16(11):909-15. PMC: 4308722. DOI: 10.1001/virtualmentor.2014.16.11.stas1-1411. View

4.
Hsieh H, Shannon S . Three approaches to qualitative content analysis. Qual Health Res. 2005; 15(9):1277-88. DOI: 10.1177/1049732305276687. View

5.
Koester K, Amico R, Gilmore H, Liu A, McMahan V, Mayer K . Risk, safety and sex among male PrEP users: time for a new understanding. Cult Health Sex. 2017; 19(12):1301-1313. DOI: 10.1080/13691058.2017.1310927. View